Literature DB >> 8649772

HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation.

P Massimi1, D Pim, A Storey, L Banks.   

Abstract

The major transforming protein of HPV-16 is encoded by the E7 gene. This has been shown to cooperate with EJ-ras in the immortalisation of primary rodent cells and with the viral E6 gene in the immortalisation of primary human keratinocytes. HPV-16 E7 protein has been shown to bind to a number of cellular proteins involved in the control of cell growth; including pRB, p107 and cyclin A. Loss of pRb or p107 binding results in the loss of transforming activity. In this paper we demonstrate that HPV-16 E7 can also complex with the core component of TFIID, the TATA Box Binding Protein (TBP). This interaction is partly dependent upon phosphorylation of the E7 protein by cellular casein kinase II (CKII), since phosphorylation of E7 by CKII increases the affinity with which E7 binds TBP. Similar results are also obtained with the Adenovirus Ela protein, indicating a conservation of function between these two viral oncoproteins. Mutation of the CKII site to two acidic amino acids significantly increases the affinity of E7 for TBP, indicating that the incorporation of two negative charges at this region of E7 is important in regulating the interaction with TBP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8649772

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

1.  Synergism with germ line transcription factor Oct-4: viral oncoproteins share the ability to mimic a stem cell-specific activity.

Authors:  A Brehm; K Ohbo; W Zwerschke; V Botquin; P Jansen-Dürr; H R Schöler
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

Review 2.  Molecular interactions of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression.

Authors:  Oishee Chakrabarti; Sudhir Krishna
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

Review 3.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

4.  Inhibition of human papillomavirus type 16 E7 phosphorylation by the S100 MRP-8/14 protein complex.

Authors:  Sharof Tugizov; Jennifer Berline; Rossana Herrera; Maria Elena Penaranda; Mayumi Nakagawa; Joel Palefsky
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator.

Authors:  Noor Gammoh; Helena Sterlinko Grm; Paola Massimi; Lawrence Banks
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 6.  The human papillomavirus E7 oncoprotein as a regulator of transcription.

Authors:  William K Songock; Seong-Man Kim; Jason M Bodily
Journal:  Virus Res       Date:  2016-11-08       Impact factor: 3.303

7.  Regulation of the human papillomavirus oncoproteins by differential phosphorylation.

Authors:  P Massimi; D Pim; C Kühne; L Banks
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

8.  Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.

Authors:  I Martinez; A S Gardiner; K F Board; F A Monzon; R P Edwards; S A Khan
Journal:  Oncogene       Date:  2007-11-12       Impact factor: 9.867

9.  Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7.

Authors:  Wanxia He; Doug Staples; Clark Smith; Chris Fisher
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Casein kinase II interacts with the bZIP domains of several transcription factors.

Authors:  Y Yamaguchi; T Wada; F Suzuki; T Takagi; J Hasegawa; H Handa
Journal:  Nucleic Acids Res       Date:  1998-08-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.